Passage Bio
Kathleen Borthwick is an experienced finance executive currently serving as Chief Financial Officer at Passage Bio. Previously, Kathleen held various leadership roles at Johnson & Johnson, including Group Finance Lead for Medical Devices and Senior Director for Janssen EMEA Mid-Sized Markets, as well as Senior Director of Manufacturing & Technical Operations Finance for Janssen Supply Group. Kathleen holds a BS in Accounting and Health Care Management from the University of Pennsylvania and an MBA from The Tuck School of Business at Dartmouth.
This person is not in any offices
Passage Bio
1 followers
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).